| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/27/1999 | US5929063 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 07/27/1999 | US5929056 Accesible from readily available starting materials to be used for wound healing and in cosmetics |
| 07/27/1999 | US5929048 Treatment of conditions and disease |
| 07/27/1999 | US5929032 Method for treating Schwann and colon cells in vitro |
| 07/27/1999 | CA2181175C Dihydro pyrazolopyrroles |
| 07/27/1999 | CA2155837C Benzopyrans as potassium channel openers |
| 07/22/1999 | WO1999036541A1 INTERLEUKIN-1 RECEPTOR ANTAGONIST BETA (IL-1RAβ) |
| 07/22/1999 | WO1999036424A1 Piperazino derivatives as neurokinin antagonists |
| 07/22/1999 | WO1999036420A1 Thiophene nitrone compounds |
| 07/22/1999 | WO1999036415A1 Thioether furan nitrone compounds |
| 07/22/1999 | WO1999036409A1 Metabolically inert anti-inflammatory and anti-tumor antifolates |
| 07/22/1999 | WO1999036393A1 INHIBITORS OF α4 MEDIATED CELL ADHESION |
| 07/22/1999 | WO1999036095A1 PHARMACEUTICAL COMPOSITIONS COMPRISING A COMPOUND HAVING DOPAMINE (D2) RECEPTOR AGONIST ACTIVITY AND A COMPOUND (B) HAVING β2-ADRENORECEPTOR AGONIST ACTIVITY |
| 07/22/1999 | WO1999036069A1 Il-8 receptor antagonists |
| 07/22/1999 | WO1999036052A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative |
| 07/22/1999 | WO1999021830A8 Process for stereoselective synthesis of prostacyclin derivatives |
| 07/22/1999 | CA2318555A1 Thiophene nitrone compounds |
| 07/22/1999 | CA2318357A1 Thioether furan nitrone compounds |
| 07/22/1999 | CA2318195A1 Il-8 receptor antagonists |
| 07/22/1999 | CA2317956A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative |
| 07/22/1999 | CA2317760A1 Piperazino derivatives as neurokinin antagonists |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929571A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 07/21/1999 | EP0929554A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 07/21/1999 | EP0929549A1 Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors |
| 07/21/1999 | EP0929516A1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 07/21/1999 | EP0929315A2 Cross-protective equine herpesvirus preparations and method of making and using the same |
| 07/21/1999 | EP0929302A1 Il-8 receptor antagonists |
| 07/21/1999 | CN1223651A Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors |
| 07/21/1999 | CN1223139A Yanminling nose-spraying agent and preparation process |
| 07/20/1999 | US5925654 Antiinflammatory agents and enzyme inhibitors |
| 07/20/1999 | US5925649 Ascomycins |
| 07/20/1999 | US5925636 Inhibitors of tumor necrosis factor, phosphodiesterase |
| 07/20/1999 | US5925624 Antiinflammatory agents treating patients with inflammatory conditions susceptible to leukocyte-induced tissue damage |
| 07/20/1999 | US5925557 This invention relates generally to the field of protein kinases, oncogenes and oncoproteins and, specifically, to a protein kinase which phosphorylates and potentiates the activity of c-fos. |
| 07/15/1999 | WO1999035266A2 Human urotensin ii |
| 07/15/1999 | WO1999035252A2 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035163A1 Phenylalanine derivatives |
| 07/15/1999 | WO1999035158A1 36 human secreted proteins |
| 07/15/1999 | WO1999035116A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments |
| 07/15/1999 | WO1999034834A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/15/1999 | WO1999034798A1 Method for treating copd |
| 07/15/1999 | CA2317720A1 Method for treating copd |
| 07/15/1999 | CA2317702A1 36 human secreted proteins |
| 07/15/1999 | CA2316864A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2256793A1 New compound intended by way of oromucous membrane notably pernasal |
| 07/14/1999 | EP0928792A2 Bicyclic(3.1.0)hexanes and related compounds |
| 07/14/1999 | EP0928789A1 6-phenyltetrahydro-1,3-oxazin-2-one derivatives and medicinal compositions containing the same |
| 07/14/1999 | EP0928291A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 07/14/1999 | CN1222369A Compound asthma capsule and its preparation |
| 07/13/1999 | US5922887 Novel delta opiod modulators for the treatment or prophylaxis of pain, organ transplant rejection, diarrhea, epileptic seizures, neurological diseases, and other disorders |
| 07/13/1999 | US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 07/13/1999 | US5922741 5-aminopyrazoles useful as tyrosine kinase inhibitors |
| 07/13/1999 | US5922740 Antiinflammatory agents |
| 07/13/1999 | US5922735 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 07/13/1999 | US5922571 Polynucleotides encoding a protein kinase C homolog |
| 07/13/1999 | US5922346 A mixtures of reduced glutathione, selenium or a selenium compound for reducing free radical damage induced by tobacco products and environmental pollutants |
| 07/13/1999 | US5922344 Product for prevention of respiratory virus infection and method of use |
| 07/13/1999 | US5922306 Inhalants dispersion comprising tetrafluoroethane/1,1,1,2-/ propellant, drug particles precoated with surfactant, the drug formulation consists of betamethasone, ergotamine tartrate or sodium cromoglycate for respiratory system disorders |
| 07/08/1999 | WO1999033989A2 Rantes mutants and therapeutic applications thereof |
| 07/08/1999 | WO1999033974A1 Serine proteinase inhibitors |
| 07/08/1999 | WO1999033859A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 07/08/1999 | WO1999033851A1 N-het-substituted glycerophosphoethanolamines |
| 07/08/1999 | WO1999033834A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/08/1999 | WO1999033827A1 Novel imidazole derivatives |
| 07/08/1999 | WO1999033806A1 4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor |
| 07/08/1999 | WO1999033789A1 SUBSTITUTED β-ALANINES |
| 07/08/1999 | WO1999025686B1 Cyclic amine derivatives and their use as drugs |
| 07/08/1999 | WO1999011275A9 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 07/08/1999 | WO1999009955A3 Lipid-containing compositions and uses thereof |
| 07/08/1999 | WO1998045711A3 Assay for ligands to tyrosine kinase receptors |
| 07/08/1999 | CA2316341A1 4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor |
| 07/08/1999 | CA2316235A1 Substituted .beta.-alanines |
| 07/08/1999 | CA2315144A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/07/1999 | EP0927763A2 Novel aroA |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927257A2 Human protein kinases |
| 07/07/1999 | EP0927192A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/07/1999 | EP0927191A2 Anti-inflammatory peptides and uses thereof |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927182A2 Alkylated rapamycin derivatives |
| 07/07/1999 | EP0927170A1 Piperazino derivatives as neurokinin antagonists |
| 07/07/1999 | EP0927168A1 1,3-diheterocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927150A1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 07/07/1999 | EP0927037A1 Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| 07/07/1999 | EP0927031A1 Pharmaceutical preparation containing nimesulide for oral administration |
| 07/07/1999 | CN1222193A Extracellular matrix signalling molecules |
| 07/07/1999 | CN1221624A Syrup for treating cough and asthma and its prodn. tech. |
| 07/07/1999 | CN1221569A Dongxing cold and refreshing tea |
| 07/07/1999 | CN1043997C 2,6-diaminopurine derivatives, its use and medicinal compsns. containing same |
| 07/06/1999 | US5919943 Inhibition of spla2 |
| 07/06/1999 | US5919904 Response regulator polypeptides; screening for bactericides |
| 07/06/1999 | US5919810 1H-indole-3-glyoxylamide sPLA2 inhibitors |
| 07/06/1999 | US5919801 N-substituted piperidines as PDE4 inhibitors |
| 07/06/1999 | US5919789 Xanthines and their therapeutic use |
| 07/06/1999 | US5919774 Novel compounds such as 2-(1-benzyl-2,5-dimethyl-4-(2-carboxyphenylmethyl)pyrrol-3-yl) glyoxamide for inhibiting human nonpancreatic secretory phospholipase a2 (spla2) mediated release of fatty acids in a mammal |
| 07/06/1999 | US5919664 For screening for antibacterial compounds |
| 07/06/1999 | US5919637 Method for identifying reduced binding between GMP-140 and GMP-140 ligand |
| 07/06/1999 | CA2177146C Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 07/06/1999 | CA2017920C Beta-lactam elastase inhibitors |